Home Generics Biosimilars Docs & Positions Facts & Figures Press Room Conferences

Media Kit

General Information

Members of the press should not hesitate to contact us by phone or e-mail at our Brussels office for any additional information about the EGA, the generic medicines industry, or any specific policy issue.

To help us respond better to your request, please be prepared give us your name, the name of your publication, your deadline, and details about your article to help us provide the information you need.

In the meantime, the following links will provide you with rapid access to some basic background information.

EGA - The European Generic medicines Association


EGA Brochure

A quick and easy introduction to the aims and goals of the EGA in one document (pdf file: 800kb).

Generic Medicines and Biosimilar Products


EGA Factsheets on Generic Medicines

Index to short articles with facts and figures on 10 key issues pertaining to generic medicines.
• July 2007

FAQ on Generic Medicines

• September 2007

FAQ on Biosimilar Medicinal Products

• September 2007


EGA FOCUS on Generic Medicines - No 1

• Paediatric Medicines: Maximising Benefits for Children
• Lisbon Strategy: Research Funds & Generic Competition
• EU Overtakes US on Developing Biogenerics

EGA FOCUS on Generic Medicines - No 2

• Fractured Markets Limits Benefits from Generics
• Generics adn Sustainable Healthcare
• EU Responds to WTO Agreement on Compulsory Licensing

EGA FOCUS on Generic Medicines - No 3

• Generic Competition and Pricing & Reimbursement Policy
• Ensuring Quality, Safety & Efficacy
• Bad Implementation of New Medicines Legislation
• Generics for Afghanistan

EGA FOCUS on Generic Medicines - No 4

• KUL Report on Measures to Promote Generics
• Patent Linkage Contrary to EU Law, Threatens Generics
• Biosimilars: Access to Medicines and EU Competitiveness

EGA FOCUS on Generic Medicines - No 5

• Missing Out on Generic Savings?
• EGA in the Pharma Forum
• Real Rewards for Real Innovation